Erythropoietin Reduces Insulin Resistance via Regulation of Its Receptor-Mediated Signaling Pathways in db/db Mice Skeletal Muscle

Erythropoietin (EPO) can reduce insulin resistance (IR) in adipocytes; however, it is unknown whether EPO can decrease IR in skeletal muscle. Here we investigated whether EPO could reduce IR in type 2 diabetic mouse skeletal muscle and its possible signaling mechanisms of action. Twelve-week-old db/...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yu, Yang, Xiu Hong, Guo, Li Li, Gu, Yan Hong, Qiao, Qing Yan, Jin, Hui Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666531/
https://www.ncbi.nlm.nih.gov/pubmed/29104499
http://dx.doi.org/10.7150/ijbs.19752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666531/
https://www.ncbi.nlm.nih.gov/pubmed/29104499
http://dx.doi.org/10.7150/ijbs.19752

Ejemplares similares